World Health Organization Temporarily Drops Hydroxychloroquine From Global Study
Courtesy: MGN
As featured on
U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Trump for treating COVID-19.
The World Health Organization said that it will temporarily drop hydroxychloroquine from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.
Get up-to-the-minute news sent straight to your device.